While the fate of the new vaccine was being studied, the company had gambled millions of dollars by beginning full-scale production of the as-yet-unapproved vaccine. This plan, however, benefited millions of people. Within one week after the Salk vaccine was approved in 1955, Lilly distributed nearly three million doses of its vaccine. By year's end, it had shipped more than 20-million doses.Use of this image is restricted to projects related to Destination Indiana. IHS may not reproduce.Eli Lilly and Company - Polio Journe
To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.